to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Although the compensation structure for venture capital funds may not be ideal, it does not appear to be changing anytime soon. Read more about the pros and cons of the VC pay model.
Many would agree that surgeons are qualified to create innovative medical devices that may be superior to what is currently available. But the controversy arises when surgeons begin to profit by purchasing their own products for use in their patients.
This sample term sheet for a Series A round of financing details the major points of a hypothetical investment deal for a first-round ?Series A Convertible Preferred Stock? financing.
Raising money by selling equity to investors is a rare activity for companies, says CommonAngels' James Geshwiler. Not many CEOs get much practice or guidance on how to do this key task. This document is a sample template for entrepreneurs to use in pitching their companies to angel investors, and covers six main areas of risk and ability to generate return for investors.
Today's revolutionary breakthroughs are yesterday's crazy ideas. And Peter Diamandis, chairman and CEO of the X PRIZE Foundation and entrepreneur behind numerous commercial space travel ventures, speaks at length about finding support for new business frontiers that, literally, are out of this world.
Something extraordinary happened in Kansas City last Thursday. For the second year in a row, some of Kansas City's largest organizations participated in a reverse pitch. KCNext, the host and organizer, brought in a capacity crowd of over 200 entrepreneurs and other Global Entrepreneurship Week event participants. There were 65 events in Kansas City spread across a week and a half. But this event was different. This one was special.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
Recognizing the needs of technology start-ups, Bob Guller started an organization that provides space and support.
Terry Bruggeman shares the tale of leading his life sciences company through the decision to obtain capital. After exploring the funding options, including VC and IPO, Bruggeman and his team decide to undertake a reverse merger.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.